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Abstract
Background: Only 2 % of the human genome code for proteins. Among the remaining 98 %, transposable elements
(TEs) represent millions of sequences. TEs have an impact on genome evolution by promoting mutations. Especially,
TEs possess their own regulatory sequences and can alter the expression pattern of neighboring genes. Since they can
potentially be harmful, TE activity is regulated by epigenetic mechanisms. These mechanisms participate in the
modulation of gene expression and can be associated with some human diseases resulting from gene expression
deregulation. The fact that the TE silencing can be removed in cancer could explain a part of the changes in gene
expression. Indeed, epigenetic modifications associated locally with TE sequences could impact neighboring genes
since these modifications can spread to adjacent sequences.
Results: We compared the histone enrichment, TE neighborhood, and expression divergence of human genes
between a normal and a cancer conditions. We show that the presence of TEs near genes is associated with greater
changes in histone enrichment and that differentially expressed genes harbor larger histone enrichment variation
related to the presence of particular TEs.
Conclusions: Taken together, these results suggest that the presence of TEs near genes could favor important
variation in gene expression when the cell environment is modified.
Keywords: Transposable elements, Gene regulation, Epigenetics
Background
With the advent of sequencing projects, coding genes
have been revealed to correspond to a tiny fraction of
eukaryotic genomes. In the human genome, the protein-
coding genes represent less than 2 % of the genome,
whereas repeated sequences represent more than half of
it [1]. While a large fraction of the non-coding se-
quences was first thought to bare no function [2], it is
now known to be composed of a mixture of repetitive
DNA and non-functional sequences interspersed with
non-coding RNA genes and regions that are crucial for
transcriptional and post-transcriptional regulation [3, 4].
A large part of repeated DNA is classified as transpos-
able elements (TEs). TEs are middle-repeated DNA se-
quences that have the ability to move from one position
to another along chromosomes [5, 6]. These mobile ele-
ments typically encode for all the proteins necessary for
their movement and possess internal regulatory regions,
allowing for their independent expression. Globally, two
main classes have been described according to their trans-
position intermediates. Retrotransposons use an RNA
intermediate and form the class I, composed by the LTR-
retrotransposons (endogenous retrovirus-like elements
baring Long Terminal Repeat sequences on each extrem-
ity) and the non-LTR retrotransposons LINEs and SINEs
(standing for Long- and Short- Interspersed Nuclear Ele-
ments respectively) that are the most frequent in the hu-
man genome [2]. Transposons use a DNA intermediate
and form the class II. In the human genome, TE distribu-
tion appears to be linked to gene function. Indeed, Alu
elements, a particular family of SINEs, were shown to be
absent from the neighborhood of genes implicated in tran-
scription and regulation [7]. Moreover, we have previously
shown that TE content is associated with the function of
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neighboring genes: while TE-free genes are more fre-
quently involved in development, transcription, and regu-
lation of transcription, TE-rich genes are enriched for the
functions of transport and metabolism [8].
Because of their presence in genomes, TEs have a sig-
nificant impact on genome evolution by promoting vari-
ous types of mutations [9, 10]. In particular, TEs possess
their own regulatory sequences, and they could alter the
normal expression pattern of neighboring genes while
inserted in intergenic regions [11]. As an example, the
MER20 element contributed to the origin of a novel
gene regulatory network dedicated to pregnancy in pla-
cental mammals [12] and ERV1 elements have wired
new genes into the core regulatory network of embry-
onic stem cells [13]. Moreover, the presence of SINEs
affects the expression of neighboring genes in tumor tis-
sue cells, with more gene deregulation associated with
more SINEs in the gene vicinity [14]. In human, 0.3 % of
TE insertions have been suggested for causing a disease,
i.e. one insertion in every 20–100 live births [15], and
approximately 96 new transposition events were directly
linked to single-gene diseases [16]. Overall, the human
genome harbors millions of TE insertions that could po-
tentially affect its functioning under certain conditions.
Because the effects associated with TE insertions can
potentially be harmful for the host genome, TE activity
needs to be regulated, a role that is partly undertaken by
epigenetic mechanisms.
For the past few years, epigenetic modifications have
been shown to contribute to gene expression regulation.
For example, epigenetic changes can explain part of the
variation in gene expression observed between tissues of
a single organism [17–20], or the fate of honeybees by
affecting the differentiation between the queen and the
workers [21]. These examples are likely to represent only
a tiny fraction of all the possible effects of epigenetic
processes. Three main intertwined epigenetic mecha-
nisms have been described so far: DNA methylation,
RNA interference, and histone modifications. DNA
methylation is usually occurring in the context of CpG
dinucleotides in animals and is associated with transcrip-
tion silencing in vertebrates [22–25]. RNA interference
mechanism is characterized by the synthesis of small
noncoding RNAs, which, when associated with a protein
complex, can target messenger RNAs and trigger their
degradation [26, 27]. Histone modifications correspond
to post-translational biochemical changes occurring at
particular amino acid residues of these proteins [23, 28, 29].
According to the type of histone modification, the effect
can be either compacting or relaxing the chromatin struc-
ture, which have both a direct impact on gene accessibility
for RNA polymerase and therefore on the gene expression
[19, 30]. According to the organism, the role of each epi-
genetic mechanism may be more or less predominant in
gene regulation. For example, DNA methylation is impli-
cated in a large number of cellular functions in mammals
and in plants, while it is almost absent from Drosophila
[22, 31]. In normal condition, according to the residues and
the histones, the hypermethylation of histones can be asso-
ciated with methylated and repressed DNA sequences [32].
Therefore, one might expect that global alterations of his-
tone modification patterns could disrupt gene expression.
Numerous research studies have associated epigenetic
changes with human diseases. For instance, cancer cells
harbor global epigenetic abnormalities that could have been
the initial point to tumor development [33]. For example,
CpG islands, unmethylated regions overlapping the major-
ity of human gene promoters, become hypermethylated
when associated with tumor-suppressor genes, leading to
their transcriptional silencing while the whole genome
undergoes a global hypomethylation in cancer condition
[34, 35]. Specific histone modifications, and other epigen-
etic processes, have been shown to specifically target TEs
(for reviews, see [36, 37]). While TEs are usually methylated
(and therefore silenced) in normal human cells, TE methy-
lation is abolished in cancer cells, letting the possibility for
TEs to be activated and to affect the integrity of the cell
[38, 39]. For example, specific endogenous retroviruses pro-
duce viral particles in human melanoma cells [40], TE ex-
pression is enhanced in urothelial and renal carcinoma
cells [41], in some carcinomas [42], in human leukemia [43,
44], and in human colorectal, ovarian and breast cancers
[45–48]. These activations are potentially resulting from
different epigenetic modifications occurring in a cancer cell.
The majority of the studies concerning the epigenetic alter-
ations occurring on TEs in a cancer environment have
mainly focused on DNA methylation (for a review see
[49]). While only a few studies investigated TE histone
modifications, a global loss of monoacetylation of lysine 16
and of trimethylation of lysine 20 on histone 4 has been
found associated to repetitive elements [50]. Moreover, the
spread of TE histone modifications to adjacent regions has
been observed in plants, fungi, and mouse [51–54] suggest-
ing that the presence of TEs may influence the epigenetic
state of neighboring genes. Among the different mecha-
nisms that could explain the effects of epigenetic changes
in a cancer cell, the implication of TE insertions, harmless
in normal conditions but for which epigenetic changes
could lead to a cascade of deregulation either causing
or reinforcing the tumor status of a cell, still needs to
be investigated.
Here, we first observed the variation of ten histone
modifications and TE content of genes according to
their genomic position in normal condition. We ob-
served that genes are generally more enriched in activat-
ing modifications at all chromosome locations compared
to repressive modifications. We then compared the his-
tone modification landscapes of genes in normal and
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cancer blood cell lines, according to their TE neighbor-
hood. Our results showed that the presence of TEs near
human genes is associated with greater changes in his-
tone enrichment. Finally, we could highlight that differ-
entially expressed human genes harbored larger histone
enrichment variation related to the presence of TEs.
Taken together, these results suggest that the presence
of TEs near genes could favor important variation in




Gene locations were downloaded from the Biomart ser-
ver using the Martview tool [55] (www.ensembl.org/bio-
mart/martview/) on the last version of the human
genome (GRCh37.p10 = hg19). Over a total of 62,380
genes in the human genome, we filtered for protein
coding genes located on the 22 autosomal and the two
sexual chromosomes, removing those located on the mito-
chondrial genome and unidentified chromosomes, and re-
trieved 19,071 genes. For each gene, Ensembl identification
number, strand orientation, and localization (start and end
positions on the chromosome) were collected.
TE insertions in human genome were previously identi-
fied using RepeatMasker [56], a program that determines
the occurrences of sequences with homology to consensus
TE sequences present in the Repbase database [57] and
were retrieved from the website of the University of
California, Santa Cruz (ftp://hgdownload.cse.ucsc.edu/
goldenPath/hg19/chromosomes/). The RepeatMasker out-
put files were parsed using the program “One code to find
them all” [58] (with the –strict option) to assemble each
TE copy and determine their localization.
Locations of histone modifications produced by
ChIP-seq experiments were downloaded for the last
version of the human genome on the ENCODE Gen-
ome Browser (http://hgdownload.cse.ucsc.edu/golden-
Path/hg19/encodeDCC/wgEncodeBroadHistone/). They
correspond to broader regions of enrichment (broadPeaks)
[59]. These regions were retrieved for 10 histone modifica-
tions (H3K4me1, H3K4me2, H3K4me3, H3K9ac,
H3K9me3, H3K27ac, H3K27me3, H3K36me3, H3K79me2,
and H4K20me1) and for two different conditions: a lym-
phoblastoid cell line originated from normal peripheral
blood lymphocyte of a female donor (GM12878 named
“normal condition”) and a leukemic cell line originated
from derived from a female patient with chronic myeloid
leukemia (K562 named “cancer condition”). The two
replicates of expression data obtained by RNA-seq ex-
periments were retrieved for the two different condi-
tions (GM12878 and K562) on the ENCODE Genome
Browser (http://hgdownload.cse.ucsc.edu/goldenPath/
hg19/encodeDCC/wgEncodeCaltechRnaSeq/).
Mean histone enrichment for each gene
To determine the mean histone enrichment of each gene
for a given histone modification, we computed the aver-
age fold enrichment ε of the histone modifications for
the positions covered by an entire gene, normalized by
the gene size (E1). We chose not to focus only on the
promoter region since it has been shown that some of
the modifications can be enriched also along the tran-
scribed region of a gene with very different levels of en-




n  l ð1Þ
with h the histone modification, n the number of values
of fold enrichment of the histone modification h mapped
within the gene, ei the value of enrichment of the his-
tone modification h at position i mapped within the
gene, and l the length of the gene.
Computation of the density and coverage of TEs in the
vicinity of genes
To estimate the amount of TEs within and around genes,
we first used each TE position to allocate it to a gene
vicinity, using a 2 kb-flanking region upstream, to include
gene promoters, and downstream the gene [8]. Then, for
each gene, the density in TEs reported as the number of
insertions per base pair (E2) and the coverage in TEs, in
percentage of the gene (E3), were computed in general for
all TEs and for each TE type (DNA transposons, LTR-
retrotransposons, LINEs, and SINEs).
Dg ¼ NLg−LTE ð2Þ
Cg ¼ LTELg ð3Þ
with g the gene, N the number of TEs, Lg the length of
the gene plus its 2 kb-flanking region, and LTE the num-
ber of nucleotides annotated as TEs in the region
encompassing the given gene.
These two different metrics were used because the
number of TEs associated with a gene is affected by
the size of the gene and its flanking region, and by
its own size. Whereas the density rather estimates the
number of insertions, the coverage measures the pro-
portion of nucleotides belonging to an element in the
sampled sequence. The relationship between these
two statistics was tested by a Spearman correlation
test.
Genes were clustered according to their level of density
and coverage of TEs using the pam() function of the R
package [62]. This algorithm, called “Partitioning Around
Medoids”, provides a robust clustering method because
outliers have a less important impact than in the k-means
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method often used for clustering [63]. The main difference
between the two methods is that pam() uses a
minimization of dissimilarities instead of a sum of Euclid-
ean distances, and that the medoids (center of a cluster) is
an actual point within the dataset. The genes with density
and coverage equal to 0 were defined as TE-free genes
(4,300 genes). The remaining 14,771 genes were clustered
with the pam() function to discriminate between the TE-
intermediate (9,132 genes) and the TE-rich genes (5,639
genes). To have more precise information concerning the
influence of particular TE types, we also classified the
14,771 genes according to the density and coverage for
each particular TE type using the pam() function. We thus
determined 11 different categories: the all-TE-
intermediate and all-TE-rich categories that correspond to
genes with respectively intermediate and rich levels for
every TE types, and the SINE-rich, LINE-rich, DNA-rich,
LTR-rich, SINE-intermediate, LINE-intermediate, DNA-
intermediate, LTR-intermediate, plus a “mix” category,
which contains genes with a combination of TE types. To
avoid any confounding factors due to the simultaneous
presence of different types of TE near genes, we applied a
strict rule to determine the category. For example LINE-
intermediate genes are free from other TE types.
Differential gene expression and functional analyses by
GO term enrichments
RNAseq reads from both samples GM12878 and K562
were trimmed to ensure sequencing quality using the
unsupervised approach of the program UrQt [64] and
aligned against human genes using Tophat2 [65]. Align-
ment counts were obtained on sorted bam files using
htseq-count [66], and differential gene expression was
assessed using DESeq2 [67]. We used an adjusted p-
value threshold <0.1 for significance, which allowed us
to identify 7,724 genes differentially expressed over the
19,071 total protein coding genes. We determined the
enrichment in particular GO terms in a list of target
genes (for example down-regulated genes in cancer con-
dition) by comparing it with the list of all the genes in
the genome using GOrilla [68] and REVIGO [69].
Statistical analyses
All statistical analyses were performed using the R soft-
ware [62]. To account for multiple testing and to be
conservative, we used the Bonferroni correction and
considered significant the results with p values < 0.05/n,
n being the number of tests realized.
Results
Histone modifications and TE enrichment of genes vary
according to the gene position on chromosome
We observed the mean histone enrichment of genes
according to gene position on chromosomes in normal
condition (Fig. 1a, Additional file 1 for each chromo-
some). We split each chromosome in bins representing
5 % of the total chromosome length, i.e., genes located
in terminal regions of the chromosomes are located in
bins 5 % and 100 %. Independently of the chromosome
location and for both sex and autosomal chromosomes,
genes are on average less enriched for repressive histone
modifications than for activating histone modifications.
However, there are some local variations according to
the histone modification. On sex chromosomes,
H3K27ac is particularly enriched at four locations. In
each case, this is due to a small subset of genes that dis-
play particularly high enrichment for this modification
(Additional file 2). Some of these genes are also respon-
sible for the peak corresponding to a high level of enrich-
ment for H3K4me3. Less important peaks of mean
enrichment are also observed on autosomal chromosomes
for three locations, which concern the same histone modi-
fications in addition to H3K9ac (Additional file 3).
We also observed the variation in TE density and TE
coverage of genes according to their location on chro-
mosomes. As both metrics are highly correlated (r =
0.95, p < 2.2e-16), either of them can be used to deter-
mine the TE richness of each gene vicinity. Globally, TE
density and TE coverage values tend to be lower for
genes located on sex chromosomes than for autosomal
genes (Fig. 1b, Additional file 4 for each chromosome).
Moreover, the level of variation in TE density and TE
coverage of genes is more important for genes located
on sex chromosomes than for autosomal. Especially,
genes located on the bin 30 % of the sex chromosomes
display a higher TE density and coverage than the genes
from the other part of these chromosomes.
The presence of TEs is locally associated with greater
changes in the chromatin environment of genes between
normal and cancer conditions
We determined how the histone enrichment of genes
varies between the two conditions, normal and cancer.
There is no clear general pattern of enrichment or de-
pletion in activating modifications associated with can-
cer (Fig. 2). However, except the activating modification
H3K79me2, all modifications display different profiles of
enrichment between the two conditions (Wilcoxon
paired tests, p < 0.005). For example, genes are on aver-
age more enriched in H3K27ac in normal condition
compared to the cancer condition, when it is the reverse
for the H3K27me3 modification.
To determine if the presence of TEs near genes may
be associated with greater changes in histone modifica-
tions of genes between the two conditions, we computed
the mean histone enrichment for the genes according to
their TE category: TE-free, TE-intermediate or TE-rich
(Fig. 3). For each condition, we found that some histone
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modification enrichments vary when comparing TE-rich
and TE-free genes (Additional file 5; Wilcoxon tests, p <
1.67e-3). For example, in normal condition, TE-rich
genes are more than twice enriched for H3K9ac than
TE-free genes (εH3K9ac = 15.49 and 6.01 respectively, p <
2.2e-16). We then compared the histone enrichment for
each gene between the two conditions and we observed
that excepted for H3K79me2 in all gene categories and
for H3K27ac in TE-free and TE-rich genes, the histone
enrichment is different between the two conditions inside
each gene category (Wilcoxon paired tests, p < 8.3e-4).
TE-rich genes are more enriched in H3K9ac in normal
condition than in cancer condition (εH3K9ac = 15.49 and
7.98 respectively, p < 2.2e-16). However, TE-rich genes are
more enriched in H3K4me2 and H3K27me3 in cancer
condition (εH3K4me2 = 12.72 and εH3K27me3 = 4.13) com-
pared to the normal condition (εH3K4me2 = 9.15 and
εH3K27me3 = 1.87, p < 2.2e-16 and p < 2.2e-16 respectively).
The previous analyses showed that histone enrichment
does vary according to the TE content in the neighbor-
hood of genes. However, it is not expected that particu-
lar levels of enrichment could be systematically
associated to the presence or absence of TEs. We tested
whether the presence of TEs is associated with a greater
a
b
Fig. 1 a. Distribution of the mean histone enrichment along sex and autosomal chromosomes for the 10 histone modifications in the normal
condition (GM12878). b Distribution of the TE density and TE coverage of genes along sex and autosomal chromosomes
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variation in histone enrichment between the two condi-
tions, whatever the level of enrichment. To determine
any over or under-representation of each gene category
according to their proportion in the genome, we com-
pared their number to (i) the number of genes displaying
similar enrichment in normal and cancer conditions,
and (ii) the number of genes displaying significantly dif-
ferent enrichment between the two conditions. The re-
sults are presented on Fig. 4. Chi2 homogeneity tests
showed that distribution of the number of genes from
each TE-content category is significantly different when
considering variation in histone enrichment compared
to their distribution in the whole-genome (p < 0.0025).
Globally, the TE-free genes are more frequently showing
similar histone modification enrichment in the two con-
ditions, while TE-rich genes tend to exhibit differences.
For example, the genes without variation in histone en-
richment between normal and cancer conditions for
H3K4me1 and H4K20me1 are more represented by TE-
free genes compared to their proportion in the genome
(respectively 52.79 and 34.52 %, instead of 22.55 %). For
the same histone modifications, in the genes that exhibit
different histone enrichment between normal and cancer
conditions, the proportion of TE-free genes decreases
(15.68 % or H3K4me1, and 15.13 % for H4K20me1)
whereas the proportion increases for the TE-
intermediate (50.35 % for H3K4me1 and 49.57 % for
H4K20me1) and TE-rich genes (33.97 % for H3K4me1,
and 35.30 % for H4K20me1). Taken together, these re-
sults indicate that a gene with TEs in its vicinity is more
likely to have a change in histone enrichment between
the two conditions compared to a TE-free gene.
In some particular cases, TEs can be associated with
various histone modifications according to their classes
[70, 71]. To determine if similar patterns were found
when considering TE types individually, we computed
Fig. 2 Mean histone enrichment of genes for the 10 histone modifications in the two conditions: normal (GM12878) and cancer (K562). The
modifications known to participate in the expression of genes or to be associated with open chromatin are represented in green. Those known
to induce gene repression or to be associated with closed chromatin are represented in red. Vertical bars indicate the mean +/− standard errors
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the mean differential enrichment of genes between nor-
mal and cancer conditions according to the TE type in
the gene neighborhood for each histone modification
(Fig. 5 and Additional file 6). The presence of different
types of TEs near genes is associated with different
effects (Kruskal Wallis, tests p < 0.005). In particular,
SINE-rich, LTR-intermediate, and TE-free genes are
more enriched for H3K4me3 in normal condition,
whereas LINE-rich, LINE-intermediate, and all-TE-rich
genes are more enriched for this modification in cancer
condition.
Differentially expressed genes between normal and
cancer conditions have particular histone enrichment
variations and TE environment
To test a possible association between the presence of
TEs, particular histone enrichment, and gene expression,
we analyzed in more detail the 7,699 genes differentially
expressed between the two conditions for which histone
modifications were associated, the 25 missing genes
being located on unidentified chromosomes. Down-
regulated genes in the cancer condition compared to
normal one are enriched for functions in the regulation
of lymphocyte activation, the defense response, and the
immune system process. Up-regulated genes are
enriched for functions in cytoskeleton organization, cell
cycle process, sulfur compound biosynthesis, regulation
of vesicle mediated transport, single organism cell process,
and post-translational protein folding (Additional file 7).
We have also compared our datasets of down- and up-
regulated genes to the set of census cancer genes identi-
fied in the COSMIC database (http://cancer.sanger.ac.uk/
cosmic; [72]). The results show that among the 596 census
genes that have been identified as “cancer genes”, meaning
genes for which mutations have been causally implicated
in cancer, 156 and 120 correspond to genes from our sets
of down- and up-regulated genes respectively.
The mean histone enrichment of up- and down-
regulated genes in cancer condition in comparison to
the normal one is reported in Table 1, for both condi-
tions. The histone enrichment is significantly different
between the two conditions for all modifications, and for
up- and down-regulated genes (Wilcoxon paired tests, p
< 0.0025) with the only exceptions of H3K4me2 for
down-regulated genes and H3K27me3 for up-regulated
genes. Both up- and down-regulated genes display the
same pattern with more enrichment in normal condition
for H3K27ac, H3K36me3, H3K9me3, H3K9ac, and more
enrichment in cancer condition for H4K20me1. It is
therefore unlikely that the divergence of expression in
response of the cancer is due to these modifications.
However, up-regulated genes are more enriched for
H3K4me1, H3K4me2, H3K4me3, and H3K79me2 in
cancer condition whereas the down-regulated genes are
depleted for these activating modifications in the same
condition (except for H3K4me2, which displays no dif-
ference between the normal and cancer conditions).
Symmetrically, down-regulated genes are more enriched
in cancer condition for the repressive histone modifica-
tion H3K27me3 whereas up-regulated genes do not
show variation between the two conditions. These differ-
ences could potentially explain the divergence of expres-
sion of these genes between the two tested conditions.
In order to determine if some particular functions could
Fig. 3 Heatmap of the mean enrichment for the 10 histone modifications of genes according to the TE category of their neighborhood in the
two conditions: normal (GM12878) and cancer (K562). The number of genes of each category is given (n). High enrichments are toward yellow
color whereas low enrichments are toward dark blue color
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be more represented among these genes, we looked at
the Gene Ontology terms of the most highly down-
regulated genes that are TE-rich and enriched in
H3K27me3 in cancer condition (Additional file 8). Inter-
estingly, seven out of the 15 genes are implicated in
immune system process and response to stress, among
which one gene, LCK, is identified as a “cancer gene” in
the COSMIC database. Similarly, we looked at the most
highly up-regulated genes that are either TE-
intermediate or TE-rich, and enriched in H3K79me2
(Additional file 9). In that case, there is less common
GO terms but we can notice that among the 43 genes,
six are involved in immune system process and response
to stress, and four are involved in transcription from
RNA polymerase II. Among the genes from this last
category, two have been identified as “cancer genes”
in the COSMIC database (GATA1 and GATA2).
The TE environment appears to be associated with the
variation in histone modifications observed between the
up- and down-regulated genes (Table 2). Among the dif-
ferentially expressed genes displaying enrichment or
depletion in particular histones, we tested whether the
number of genes regarding their local TE landscape is
different from that observed in the total genome. We
first considered the down-regulated genes with more en-
richment in H3K27me3 in cancer condition (1,514
genes) and depleted in H3K4me1 (1,649 genes),
H3K4me3 (1,420 genes), and/or H3K79me2 (1,766
genes). Globally, the proportions are different for all
comparisons (Chi2 homogeneity tests, p < 0.0055). More
specifically, there is an increase of LTR-rich genes inside
each group of genes (9.44 % (total genome) versus
17.97 % (H3K27me3), 15.46 % (H3K4me1), 14.37 %
(H3K4me3), and 16.08 % (H3K79me2)) whereas the
Fig. 4 Gene proportion according to the TE category of their neighborhood. The gene proportion is shown for the global genome and between
the two conditions (normal (GM12878) and cancer (K562)) for genes displaying the same histone enrichment and for genes displaying different
histone enrichment for the 10 histone modifications
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proportion of TE-free genes greatly decreases (22.55 %
(total genome) versus 11.23 % (H3K27me3), 14.55 %
(H3K27me3), 15.56 % (H3K4me3), and 12.85 %
(H3K79me2)). We also observe an increase in the pro-
portion of DNA-intermediate genes (0.08 % (total gen-
ome) versus 0.13 % (H3K27me3) and 0.14 %
(H3K4me3)), all-TE-intermediate genes (1.67 % (total
genome) versus 2.77 % (H3K27me3)), and all-TE-rich
genes (1.00 % (total genome) versus 2.46 % (H3K4me3)
and 2.38 % (H3K79me2)), but also a decrease in the pro-
portions of SINE-rich, SINE-intermediate, and LTR-
intermediate genes. Among the up-regulated genes that
display enrichment in H3K4me1 (2,334 genes),
H3K4me2 (2,345 genes), H3K4me3 (2,583 genes),
and/or H3K79me2 (1,819 genes), the proportions of
SINE-rich, DNA-intermediate, and LTR-rich genes in-
crease whereas the proportions of LINE-intermediate,
LTR-intermediate, and TE-free genes decrease.
Discussion
In this work, we showed that genes are generally more
enriched for activating histone modifications than for
Fig. 5 Differential histone enrichment between normal (GM12878) and cancer (K562) condition for the 10 histone modifications of genes
according to the TE category of their neighborhood. The number of genes of each category is given (n). More enrichments in normal condition
are toward blue color whereas more enrichments in cancer condition are toward read color. White color corresponds to an absence of
differential enrichment between the two conditions
Table 1 Mean histone enrichment for the 10 histone modifications of genes according to their expression divergence between
normal and cancer condition
Down-regulated genes Up-regulated genes
Histone modification Normal Cancer Wilcoxon paired tests p-values Normal Cancer Wilcoxon paired tests p-values
activating H3K27ac 8.05* 7.35 <2.2e-16 13.46* 9.11 <2.2e-16
H3K9ac 8.63* 5.92 <2.2e-16 7.66* 7.39 2.78e-13
H3K36me3 2.91* 2.49 <2.2e-16 2.49* 1.65 <2.2e-16
H3K4me1 5.58* 5.28 8.99e-5 6.09 6.28* <2.2e-16
H3K4me2 9.74 9.51 0.1682 8.06 11.10* <2.2e-16
H3K4me3 6.83* 5.73 0.0002763 6.65 9.42* <2.2e-16
H3K79me2 4.03* 1.92 <2.2e-16 2.97 4.46* <2.2e-16
repressing H3K27me3 1.76 5.86* <2.2e-16 3.54 3.35 0.009098
H3K9me3 2.16* 0.96 <2.2e-16 1.69* 1.40 3.46e-7
H4K20me1 1.27 1.52* 5.56e-9 0.92 2.97* <2.2e-16
*Significantly more enrichment (p-value < 0.0025)
Grégoire et al. BMC Genomics  (2016) 17:588 Page 9 of 14























156 (9.46 %) 146 (10.28 %) 161 (9.12 %) 114 (7.53 %) 298 (12.77 %) 292 (12.45 %) 310 (12.00 %) 227 (12.48 %)
LINE-rich 972 (5.10 %) 88 (5.34 %) 82 (5.77 %) 94 (5.32 %) 80 (5.28 %) 96 (4.11 %) 107 (4.56 %) 111 (4.30 %) 78 (4.29 %)
DNA-rich 824 (4.32 %) 91 (5.52 %) 74 (5.21 %) 87 (4.93 %) 73 (4.82 %) 96 (4.11 %) 101 (4.31 %) 97 (3.76 %) 77 (4.23 %)
LTR-rich 1800
(9.44 %)
255 (15.46 %) 204 (14.37 %) 284 (16.08 %) 272 (17.97 %) 247 (11.58 %) 238 (10.15 %) 267 (10.34 %) 209 (11.49 %)
SINE-intermediate 1784
(9.35 %)
118 (7.16 %) 111 (7.82 %) 98 (5.55 %) 73 (4.82 %) 229 (9.81 %) 236 (10.06 %) 250 (9.68 %) 177 (9.73 %)
LINE-intermediate 20 (0.10 %) 0 (0.00 %) 1 (0.07 %) 1 (0.06 %) 2 (0.13 %) 1 (0.04 %) 1 (0.04 %) 0 (0.00 %) 1 (0.05 %)
DNA-intermediate 15 (0.08 %) 1 (0.06 %) 2 (0.14 %) 1 (0.06 %) 2 (0.13 %) 3 (0.13 %) 4 (0.17 %) 2 (0.08 %) 3 (0.16 %)
LTR-intermediate 63 (0.33 %) 7 (0.42 %) 5 (0.35 %) 6 (0.34 %) 1 (0.07 %) 4 (0.17 %) 5 (0.21 %) 3 (0.12 %) 3 (0.16 %)
TE-free 4300
(22.55 %)
240 (14.55 %) 221 (15.56 %) 227 (12.85 %) 170 (11.23 %) 404 (17.31 %) 407 (17.36 %) 454 (17.58 %) 314 (17.26 %)
All-TE-intermediate 191 (1.67 %) 14 (0.85 %) 6 (0.42 %) 20 (1.13 %) 16 (2.77 %) 41 (1.76 %) 40 (1.71 %) 44 (1.70 %) 37 (2.03 %)
All-TE-rich 318 (1.00 %) 27 (1.64 %) 35 (2.46 %) 42 (2.38 %) 42 (1.06 %) 25 (1.07 %) 30 (1.28 %) 32 (1.24 %) 18 (0.99 %)
Mix 6665
(34.95 %)
652 (39.54 %) 533 (37.53 %) 745 (42.19 %) 669 (44.19 %) 890 (38.13 %) 884 (37.70 %) 1013 (39.22 %) 675 (37.11 %)
P values Chi2
homogeneity tests
<2.2e-16 6.863e-14 <2.2e-16 <2.2e-16 <2.2e-16 2.208e-06 3.434e-09 5.405e-06
Total gene number 19071 1649 1420 1766 1514 2334 2345 2583 1819














repressive ones when considering all positions on chro-
mosomes, in both autosomal and sex chromosomes.
This may reflect the fact that genes are usually enriched
in regions associated to an open chromatin state [73, 74].
We did not detect any significant effect of the local gene
density on a chromosome on the histone modification en-
richment pattern (Spearman correlation tests, data not
shown). However, at a more fine scale, we know that vari-
ations among genes exist according to their function in
the tissue considered. We observed regions with high level
of enrichment for activating histone modifications, which
are due to especially high values associated to a small
number of genes. This could point to genes particularly
active in the analyzed cell line since it has been shown that
histone modification levels are good predictors of the gene
expression level [75]. When we analyzed the TE content
near genes, we observed that genes are on average more
enriched in TEs when located on autosomal chromosomes
when compared to genes present on sex chromosomes.
This is in general agreement with previous analyses made
on the TE distribution in the human genome, where the
density of some retroelements is higher on autosomal
chromosomes than on the X chromosome [76], which
could be associated with variation in the recombination
rate on these chromosomes.
We did not observe any general pattern of increase or
decrease of histone modifications according to their ef-
fect on gene expression in association with cancer com-
pared to the normal state, but the two conditions
showed significantly different landscapes for enrichment.
Variances of enrichment for some histone modifications
appear to be larger for genes in normal condition. This
points out the need to better understand how epigenetic
modifications are labile to quantify how much they vary
among normal conditions, across time, or even among
individuals, a whole body of research that is just starting
[77]. For the purpose of the study, we made the hypoth-
esis that the “within condition” variation can be esti-
mated using the large number of genes corresponding to
the whole-genome.
Our results showed that there is more variation in the
histone enrichment of genes between normal and cancer
condition, when the genes are enriched in TEs. This
could be linked to the fact that TEs can be associated to
particular epigenetic modifications. In human and
mouse, TEs are associated with H3K9me3 and
H4K20me3 [78, 79]. In mouse, an association of the
modification H3K27me3 to SINEs and gene rich regions
has been shown [80]. Histone modifications play a major
role in the global silencing of TEs in the mammal ge-
nomes, even if some variability exists regarding the TE
family [78, 79, 81, 82]. Interestingly, some of the histone
modifications are likely to be cell-type specific and could
indicate that some of them targeting TEs may regulate
the expression of “host” genes, especially if they provide
the host with a function [82]. Particular histone modifi-
cations of TEs have also been shown to spread to the
neighboring regions of the TE insertion. For example,
Intracisternal A-particle (IAP) elements, which are mod-
erately repeated TEs in mouse (~1000 copies) induce
H3K9me3 and H4K20me3 targeting on flanking regions
of their insertion [54]. A similar observation has been
made in plants, in which the insertions of TEs in eu-
chromatic regions induce the local formation of hetero-
chromatin [53, 81, 83]. Hence, the presence of particular
histone modifications associated with TEs could influ-
ence the epigenetic profile of neighboring genes, due to
the synergetic or antagonist actions of different histone
modifications [84]. In cancer condition, the global modi-
fications occurring on TEs may also spread to neighbor-
ing genes inducing changes in their expression, which in
turn would perturb various genetic networks. Indeed, in
cancer cells, silencing of tumor-suppressor genes by
hypermethylation of CpG island promoters is associated
with deacetylation of histones H3 and H4, loss of
H3K4me3, and gain of H3K9me and H3K27me3 [35,
85]. However, unmethylated tumor-suppressor genes are
silenced when hypoacetylation and hypermethylation of
histones H3 and H4 are present, indicating that only
changes of histone modifications can be sufficient to re-
press a gene [34]. A global reduction of monoacetylated
H4K16 has been observed in cancer cells, along with a
loss of the active modification H3K4me3 and of the re-
pressive modification H4K20me3, and a gain of the re-
pressive modification H3K27me3 [50, 85, 86].
Interestingly, we did not observe an association with
more repressive histone modifications for TE-rich genes
compared to TE-free genes in normal condition, as
could be expected if all TE insertions are indeed only
targeted by silencing modifications. Some of the TE in-
sertions might have been selected for their adaptive role
in the gene regulation, and therefore not silenced by the
host-genome. A theory concerning an “exaptation hy-
pothesis” has been suggested [87]. The authors proposed
that the role of TE epigenetic modifications could be
adaptive, with TEs having been recruited to participate
in the regulation of host genes, although some evidences
remained in support to the alternative hypothesis of
“genome defense”, in which epigenetic regulatory system
evolved to silence TEs and prevent their deleterious ac-
tivities. In any case, this implies that among all TE inser-
tions in a genome, not all of them will have the same
impact on gene expression, according to their impact on
natural selection.
Among the differentially expressed genes between the
two conditions and presenting variation in histone enrich-
ments, genes with particular TEs in their vicinity are over-
represented while TE-free genes are under-represented.
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This was especially clear for down-regulated genes. This
result supports a causal link between the presence of TEs,
the histone modifications and the changes in gene expres-
sion. In cancer condition, epigenetic remodeling of large
genomic region is observed, as well as a loss of control of
various epigenetic mechanisms [88, 89]. The presence of
TEs in these regions could thus trigger particular changes
in epigenetic modifications when compared to regions
devoid of TEs. Interestingly, the effect seems to change ac-
cording to the type of TEs present near genes. We showed
here that the proportion of LTR-rich genes increases
among down-regulated genes with a depletion in several
activating histone modifications and an enrichment in the
repressive modification H3K27me3 in cancer condition.
Similarly, an effect on gene expression has been observed
for L1 elements when inserted into genes, associated
with DNA hypomethylation in cancer condition [90].
In addition, we observed that LINE-intermediate and
LINE-rich genes are less represented among up-
regulated genes in cancer condition, which could be
linked to the same effect.
In this study, we have made the hypothesis that all TE
insertions currently present in the human genome are
fixed. Although it is true for the large majority of the
millions of insertions of this genome, a small number of
TE families corresponding to non-LTR retrotransposons
are known to be still active and potentially able to pro-
duce new insertions, which corresponds to a few thou-
sand active copies [16, 91]. Since in cancer conditions
more transcriptional activity of TEs has been observed,
new insertions could be generated for the families still
active. Some studies have indeed identified several hun-
dred of somatic transposition events in various cancer
tissues that were mainly found inside known cancer
genes, indicating a direct link between the new inser-
tions and the cancer development [92–95]. Novel inser-
tions may provide particular changes in the epigenetic
profiles of genes inside or near which they insert that we
would not be able to detect here. However, it would not
completely change the global pattern we observed since
these new insertions cannot change completely the TE
category of genes, except for some of the TE-free genes.
Moreover, since we focused on genes having one cat-
egory of TE in their neighborhood to avoid confounding
factors of various TE families, it is unlikely that new in-
sertions would be inserted in the genes we considered.
Although new cancer insertions may not blur the obser-
vations we made, the use of polymorphic insertions
would be especially interesting to directly measure the
influence on gene expression and epigenetic modifica-
tions according to the differential presence / absence of
active TEs near particular genes. For example, the study
of paralogous regions in the human genome has shown
that the presence of Alu elements is associated with
DNA methylation divergence, with a hypermethylated
region being closer to Alus than to their corresponding
hypomethylated copy [96]. Then the differential pres-
ence of some TE insertions could in some cases be asso-
ciated with variation in the epigenetic landscape of
genes, which may be associated to certain susceptibility
to cancer development. These polymorphic insertions
have been shown to be more numerous than somatic
cancer insertions since they can represent a few thou-
sand sequences [16, 92, 97]. However, these insertions
are usually not found near genes, as a consequence of
the direct action of natural selection, which eliminates
deleterious mutations. Then, it can be expected that not
having considered these insertions would not modify our
current results.
Conclusions
Our analyses have shown that the genomic environment
of genes is important to understand changes in gene ex-
pression when the cell undergoes changes of condition.
The presence of TEs around genes may have crucial im-
pact on their epigenetic landscape.
Additional files
Additional file 1: Figure S2. Distribution of the TE density and TE
coverage of genes along all chromosomes. (PDF 311 kb)
Additional file 2: Table S1. Mean enrichment of genes responsible for
the high mean enrichment value for H3K27ac and/or H3K4me3 at
particular positions of sex chromosomes. (PDF 207 kb)
Additional file 3: Table S2. Mean enrichment of genes responsible for
the high mean enrichment value for H3K27ac H3K4me3 and/or H3K9ac
at particular positions of autosomal chromosomes. (PDF 260 kb)
Additional file 4: Figure S1. Distribution of the mean histone
enrichment along all chromosomes for the 10 histone modifications in
the normal condition (GM12878). The chromosome Y is not represented
since all of its 45 genes did not present any histone enrichment values.
(PDF 252 kb)
Additional file 5: Table S3. Mean values of histone enrichment for
each histone modification and for each gene category. (PDF 231 kb)
Additional file 6: Table S4. Differential mean values of enrichment for
each histone modification and for each gene category according to the
TE type. (PDF 31 kb)
Additional file 7: Table S5. GO function of down- and up-regulated
genes between normal and cancer condition. (XLSX 870 kb)
Additional file 8: Table S6. Most highly down-regulated TE-rich genes
that are enriched for H3K27me3 in cancer condition (PDF 206 kb)
Additional file 9: Table S7. Most up-regulated TE-rich and TE-
intermediate genes that are enriched for H3K79me2 in cancer condition
(PDF 213 kb)
Abbreviations
GO, Gene Ontology; LINEs, Long Interspersed Elements; LTR, Long Terminal
Repeat; SINEs, Short Interspersed Nuclear Elements; TEs, transposable elements
Acknowledgment
This work was performed with the galaxy.prabi.fr web service and the
computing facilities of the LBBE/PRABI. We thank Rita Rebollo for helpful
comments on the manuscript and English improvement.
Grégoire et al. BMC Genomics  (2016) 17:588 Page 12 of 14
Funding
This work was supported by the CNRS.
Availability of data and material
All data used in this work are available on different public websites (see
Material and methods section for full web addresses).
Authors’ contributions
EL designed the study, LG and EL performed the analyses, EL and AH wrote
the manuscript. All authors read and approved the final version.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Received: 15 March 2016 Accepted: 27 July 2016
References
1. International Human Genome Sequencing Consortium. Finishing the
euchromatic sequence of the human genome. Nature. 2004;431:931–45.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K,
Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the
human genome. Nature. 2001;409:860–921.
3. Cordaux R, Batzer MA. The impact of retrotransposons on human genome
evolution. Nat Rev Genet. 2009;10:691–703.
4. Ludwig M. Functional evolution of noncoding DNA. Curr Opin Genet Dev.
2002;12:634–9.
5. Wicker T, Sabot F, Hua-Van A, Bennetzen JL, Capy P, Chalhoub B, Flavell A,
Leroy P, Morgante M, Panaud O, et al. A unified classification system for
eukaryotic transposable elements. Nat Rev Genet. 2007;8:973–82.
6. Kapitonov VV, Jurka J. A universal classification of eukaryotic transposable
elements implemented in Repbase. Nat Rev Genet. 2008;9:411–2.
7. Grover D, Mukerji M, Bhatnagar P, Kannan K, Samir K, Brahmachari SK. Alu
repeat analysis in the complete human genome: Trends and variations with
respect to genomic composition. Bioinformatics. 2004;20:813–7.
8. Mortada H, Vieira C, Lerat E. Genes devoid of full-length transposable element
insertions are involved in development and in the regulation of transcription
in human and closely related species. J Mol Evol. 2010;71:180–91.
9. Kidwell MG, Lisch DR. Transposable elements and host genome evolution.
Trends Ecol Evol. 2000;15:95–9.
10. Biémont C, Vieira C. Genetics: junk DNA as an evolutionary force. Nature.
2006;443:521–4.
11. Kines KJ, Belancio VP. Expressing genes do not forget their LINEs:
transposable elements and gene expression. Front Biosci. 2012;17:1329.
12. Lynch VJ, Leclerc RD, May G, Wagner GP. Transposon-mediated rewiring of
gene regulatory networks contributed to the evolution of pregnancy in
mammals. Nat Genet. 2011;43:1154–9.
13. Kunarso G, Chia N-Y, Jeyakani J, Hwang C, Lu X, Chan Y-S, Ng H-H, Bourque
G. Transposable elements have rewired the core regulatory network of
human embryonic stem cells. Nat Genet. 2010;42:631–4.
14. Lerat E, Sémon M. Influence of the transposable element neighborhood on
human gene expression in normal and tumor tissues. Gene. 2007;396:303–11.
15. Belancio VP, Hedges DJ, Deininger P. Mammalian non-LTR retrotransposons:
For better or worse in sickness and in health. Genome Res. 2008;18:343–58.
16. Hancks DC, Kazazian HH. Active human retrotransposons: Variation and
disease. Curr Opin Genet Dev. 2012;22:191–203.
17. Straussman R, Nejman D, Roberts D, Steinfeld I, Blum B, Benvenisty N, Simon I,
Yakhini Z, Cedar H. Developmental programming of CpG island methylation
profiles in the human genome. Nat Struct Mol Biol. 2009;16:564–71.
18. Varley KE, Gertz J, Bowling KM, Parker SL, Reddy TE, Pauli-Behn F, Cross MK,
Williams B, Stamatoyannopoulos J, Crawford GE, et al. Dynamic DNA
methylation across diverse human cell lines and tissues. Genome Res. 2013;
23:555–67.
19. Ha M, Ng DW-K, Li W-H, Chen ZJ. Coordinated histone modifications are
associated with gene expression variation within and between species.
Genome Res. 2011;21:590–8.
20. Ghosh S, Yates AJ, Frühwald MC, Miecznikowski JC, Plass C, Smiraglia D.
Tissue specific DNA methylation of CpG islands in normal human adult
somatic tissues distinguishes neural from non-neural tissues. Epigenetics.
2010;5:527–38.
21. Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of
reproductive status in honeybees via DNA methylation. Science. 2008;319:
1827–30.
22. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev.
2002;16:6–21.
23. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007;
128:669–81.
24. Weber M, Schübeler D. Genomic patterns of DNA methylation: targets and
function of an epigenetic mark. Curr Opin Cell Biol. 2007;19:273–80.
25. Jones PA, Liang G. Rethinking how DNA methylation patterns are
maintained. Nat Rev Genet. 2009;10:805–11.
26. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and
siRNAs. Cell. 2009;136:642–55.
27. Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat
Rev Genet. 2009;10:94–108.
28. Grant PA. A tale of histone modifications. Genome Biol. 2001;2:REVIEWS0003.
29. Peterson CL, Laniel M-A. Histones and histone modifications. Curr Biol. 2004;
14:R546–51.
30. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell.
2007;128:707–19.
31. Vanyushin BF. DNA methylation in plants. Curr Top Microbiol Immunol.
2006;301:67–122.
32. Sharma S, Kelly TK, Jones P. Epigenetics in cancer. Carcinogenesis. 2009;31:
27–36.
33. McKenna ES, Roberts CWM. Epigenetics and cancer without genomic
instability. Cell Cycle. 2009;8:23–6.
34. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer.
2004;4:143–53.
35. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification
maps. Nat Rev Genet. 2007;8:286–98.
36. Slotkin RK, Martienssen R. Transposable elements and the epigenetic
regulation of the genome. Nat Rev Genet. 2007;8:272–85.
37. Huda A, Jordan IK. Epigenetic regulation of mammalian genomes by
transposable elements. Ann N Y Acad Sci. 2009;1178:276–84.
38. Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27–56.
39. Ross JP, Rand KN, Molloy PL. Hypomethylation of repeated DNA sequences
in cancer. Epigenomics. 2010;2:245–69.
40. Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I,
Seppele H, Schanab O, Magin-lachmann C, Lo R, et al. An endogenous
retrovirus derived from human melanoma cells. Cancer Res. 2003;63:
8735–41.
41. Florl AR, Löwer R, Schmitz-Dräger BJ, Schulz WA. DNA methylation and
expression of LINE-1 and HERV-K provirus sequences in urothelial and renal
cell carcinomas. Br J Cancer. 1999;80:1312–21.
42. Smith IM, Mydlarz WK, Mithani SK, Califano JA. DNA global hypomethylation
in squamous cell head and neck cancer associated with smoking alcohol
consumption and stage. Int J Cancer. 2007;121:1724–8.
43. Depil S, Roche C, Dussart P, Prin L. Expression of a human endogenous retrovirus
HERV-K in the blood cells of leukemia patients. Leukemia. 2002;16:254–9.
44. Patzke S, Lindeskog M, Munthe E, Aasheim HC. Characterization of a novel
human endogenous retrovirus HERV-H/F expressed in human leukemia cell
lines. Virology. 2002;303:164–73.
45. Debniak T, Gorski B, Cybulski C, Jakubowska A, Kurzawski G, Kladny J,
Lubinski J. Comparison of Alu-PCR microsatelite instability and
immunohistochemical analyses in finding features characteristic for
hereditary nonpolyposis colorectal cancer. J Cancer Res Clin Oncol. 2001;
127:565–9.
46. Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, Chen D-T, Lu
DW, Barnhart KF, Johanning GL. Expression of multiple human endogenous
retrovirus surface envelope proteins in ovarian cancer. Int J Cancer. 2007;
120:81–90.
47. Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw
DR, Strong TV. Expression of human endogenous retrovirus k envelope
transcripts in human breast cancer. Clin Cancer Res. 2001;7:1553–60.
Grégoire et al. BMC Genomics  (2016) 17:588 Page 13 of 14
48. Menendez L, Benigno BB, McDonald JF. L1 and HERV-W retrotransposons
are hypomethylated in human ovarian carcinomas. Mol Cancer. 2004;3:12.
49. Chénais B. Transposable elements and human cancer: A causal relationship?
Biochim Biophys Acta. 2013;1835:28–35.
50. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G,
Bonaldi T, Haydon C, Ropero S, Petrie K, et al. Loss of acetylation at Lys16
and trimethylation at Lys20 of histone H4 is a common hallmark of human
cancer. Nat Genet. 2005;37:391–400.
51. Gendrel A-V, Lippman Z, Yordan C, Colot V, Martienssen RA. Dependence of
heterochromatic histone H3 methylation patterns on the Arabidopsis gene
DDM1. Science. 2002;297:1871–3.
52. Volpe TA, Kidner C, Hall IM, Teng G, Grewal SIS, Martienssen RA. Regulation
of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi.
Science. 2002;297:1833–7.
53. Lippman Z, Gendrel A-V, Black M, Vaughn MW, Dedhia N, McCombie WR,
Lavine K, Mittal V, May B, Kasschau KD, et al. Role of transposable elements
in heterochromatin and epigenetic control. Nature. 2004;430:471–6.
54. Rebollo R, Karimi MM, Bilenky M, Gagnier L, Miceli-Royer K, Zhang Y, Goyal
P, Keane TM, Jones S, Hirst M, et al. Retrotransposon-induced
heterochromatin spreading in the mouse revealed by insertional
polymorphisms. PLoS Genet. 2011;7:e1002301.
55. Smedley D, Haider S, Durinck S, Pandini L, Provero P, Allen J, Arnaiz O,
Awedh MH, Baldock R, Barbiera G, et al. The BioMart community portal: an
innovative alternative to large centralized data repositories. Nucleic Acids
Res. 2015;43:W589–98.
56. Smit AFA, Hubley R, Green P. RepeatMasker Open-30. 1996–2010. http://
www.repeatmasker.org
57. Jurka J, Kapitonov VV, Pavlicek A, Klonowski P, Kohany O, Walichiewicz J.
Repbase Update a database of eukaryotic repetitive elements. Cytogenet
Genome Res. 2005;110:462–7.
58. Bailly-Bechet M, Haudry A, Lerat E. ‘One code to find them all’: a perl tool to
conveniently parse RepeatMasker output files. Mob DNA. 2014;5:13.
59. ENCODE Project Consortium. An integrated encyclopedia of DNA elements
in the human genome. Nature. 2012;489:57–74.
60. Barski A, Cuddapah S, Cui K, Roh T-Y, Schones DE, Wang Z, Wei G, Chepelev
I, Zhao K. High-resolution profiling of histone methylations in the human
genome. Cell. 2007;129:823–37.
61. Barth TK, Imhof A. Fast signals and slow marks: the dynamics of histone
modifications. Trends Biochem Sci. 2010;35:618–26.
62. R core team. https://www.r-project.org/. 2015.
63. Han J Kamber M, Pei J. Data Mining: concepts and techniques. Elsevier.
2012. Morgan Kaufmann Publishers, July 2011. ISBN 978-0123814791
64. Modolo L, Lerat E. UrQt: an efficient software for the Unsupervised Quality
trimming of NGS data. BMC Bioinformatics. 2015;16:137.
65. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2:
accurate alignment of transcriptomes in the presence of insertions
deletions and gene fusions. Genome Biol. 2013;14:R36.
66. Anders S, Pyl PT, Huber W. HTSeq - A Python framework to work with
high-throughput sequencing data. Bioinformatics. 2014;31:166–9.
67. Love MI, Huber W, Anders S. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
68. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery
and visualization of enriched GO terms in ranked gene lists. BMC
Bioinformatics. 2009;10:48.
69. Supek F, Bošnjak M, Škunca N, Šmuc T. REVIGO summarizes and visualizes
long lists of gene ontology terms. PLoS One. 2011;6:e21800.
70. Montoya-Durango DE, Liu Y, Teneng I, Kalbfleisch T, Lacy ME, Steffen MC,
Ramos KS. Epigenetic control of mammalian LINE-1 retrotransposon by
retinoblastoma proteins. Mutat Res. 2009;665:20–8.
71. Rangasamy D. Distinctive patterns of epigenetic marks are associated with
promoter regions of mouse LINE-1 and LTR retrotransposons. Mob DNA.
2013;4:27.
72. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding
M, Bamford S, Cole C, Ward S, et al. COSMIC: exploring the world’s
knowledge of somatic mutations in human cancer. Nuc Acids Res. 2014;43:
D805–11.
73. Huisinga KL, Brower-Toland B, Elgin SCR. The contradictory definitions of
heterochromatin: transcription and silencing. Chromosoma. 2006;15:110–22.
74. Koch CM, Andrews RM, Flicek P, Dillon SC, Karaöz U, Clelland GK, Wilcox S,
Beare DM, Fowler JC, Couttet P, et al. The landscape of histone
modifications across 1 % of the human genome in five human cell lines.
Genome Res. 2007;17:691–707.
75. Karlić R, Chung H-R, Lasserre J, Vlahovicek K, Vingron M. Histone
modification levels are predictive for gene expression. Proc Natl Acad
Sci U S A. 2010;107:2926–31.
76. Kvikstad EM, Makova KD. The (r)evolution of SINE versus LINE distributions
in primate genomes: Sex chromosomes are important. Genome Res. 2010;
20:600–13.
77. Woo YH, Li W-H. Evolutionary conservation of histone modifications in
mammals. Mol Biol Evol. 2012;29:1757–67.
78. Kondo Y, Issa J-PJ. Enrichment for histone H3 lysine 9 methylation at Alu
repeats in human cells. J Biol Chem. 2003;278:27658–62.
79. Martens JH, O’Sullivan RJ, Braunschweig U, Opravil S, Radolf M, Steinlein P,
Jenuwein T. The profile of repeat-associated histone lysine methylation
states in the mouse epigenome. EMBO J. 2005;24:800–12.
80. Pauler FM, Sloane MA, Huang R, Regha K, Koerner MV, Tamir I, Sommer A,
Aszodi A, Jenuwein T, Barlow DP. H3K27me3 forms BLOCs over silent genes
and intergenic regions and specifies a histone banding pattern on a mouse
autosomal chromosome. Genome Res. 2009;19:221–33.
81. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P,
Brockman W, Kim T-K, Koche RP, et al. Genome-wide maps of chromatin
state in pluripotent and lineage-committed cells. Nature. 2007;448:553–60.
82. Huda A, Bowen NJ, Conley AB, Jordan IK. Epigenetic regulation of transposable
element derived human gene promoters. Gene. 2011;475:39–48.
83. Eichten SR, Ellis NA, Makarevitch I, Yeh CT, Gent JI, Guo L, McGinnis KM,
Zhang X, Schnable PS, Vaughn MW, et al. Spreading of Heterochromatin Is
Limited to Specific Families of Maize Retrotransposons. PLoS Genet. 2012;8:
e1003127.
84. Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD.
Synergistic coupling of histone H3 phosphorylation and acetylation in
response to epidermal growth factor stimulation. Mol Cell. 2000;5:905–15.
85. Füllgrabe J, Kavanagh E, Joseph B. Histone onco-modifications. Oncogene.
2011;30:3391–403.
86. Portela A, Esteller M. Epigenetic modifications and human disease. Nat
Biotechnol. 2010;28:1057–68.
87. Huda A, Mariño-Ramírez L, Jordan IK. Epigenetic histone modifications of
human transposable elements: genome defense versus exaptation. Mob
DNA. 2010;1:2.
88. Bert SA, Robinson MD, Strbenac D, Statham AL, Song JZ, Hulf T, Sutherland
RL, Coolen MW, Stirzaker C, Clark SJ. Regional activation of the cancer
genome by long-range epigenetic remodeling. Cancer Cell. 2013;23:9–22.
89. Dudziec E, Gogol-Döring A, Cookson V, Chen W, Catto J. Integrated
epigenome profiling of repressive histone modifications DNA methylation
and gene expression in normal and malignant urothelial cells. PLoS One.
2013;7:1–9.
90. Aporntewan C, Phokaew C, Piriyapongsa J, Ngamphiw C, Ittiwut C,
Tongsima S, Mutirangura A. Hypomethylation of intragenic LINE-1 represses
transcription in cancer cells through AGO2. PLoS One. 2011;6:e17934.
91. Abrusán G. Somatic transposition in the brain has the potential to influence
the biosynthesis of metabolites involved in Parkinson’s disease and
schizophrenia. Biol Direct. 2012;7:41.
92. Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ, Lohr JG, Harris
CC, Ding L, Wilson RK, et al. Landscape of somatic retrotransposition in
human cancers. Science. 2012;337:967–71.
93. Solyom S, Ewing AD, Rahrmann EP, Doucet T, Nelson HH, Burns MB, Harris
RS, Sigmon DF, Casella A, Erlanger B, et al. Extensive somatic L1
retrotransposition in colorectal tumors. Genome Res. 2012;22:2328–38.
94. Helman E, Lawrence MS, Stewart C, Sougnez C, Getz G, Meyerson M.
Somatic retrotransposition in human cancer revealed by whole-genome
and exome sequencing. Genome Res. 2014;24:1053–63.
95. Ewing AD, Gacita A, Wood LD, Ma F, Xing D, Kim M-S, Manda SS, Abril G,
Pereira G, Makohon-Moore A, et al. Widespread somatic L1
retrotransposition occurs early during gastrointestinal cancer evolution.
Genome Res. 2015;25:1536–45.
96. Prendergast JGD, Chambers EV, Semple AM. Sequence-level mechanisms of
human epigenome evolution. Genome Biol Evol. 2014;6:1758–71.
97. Rishishwar L, Tellez Villa CE, Jordan IK. Transposable element polymorphisms
recapitulate human evolution. Mob DNA. 2015;6:21.
Grégoire et al. BMC Genomics  (2016) 17:588 Page 14 of 14
